BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 14978457)

  • 1. Anxiety and depression in the elderly: implications for diagnosis and treatment.
    Dunner DL
    CNS Spectr; 2003 Dec; 8(12 Suppl 3):5. PubMed ID: 14978457
    [No Abstract]   [Full Text] [Related]  

  • 2. [Depression after age 50. Clinical case].
    Frémont P
    Encephale; 2000 Nov; 26 Spec No 5():61-2. PubMed ID: 11217527
    [No Abstract]   [Full Text] [Related]  

  • 3. [Selective serotonin and noradrenaline reuptake inhibitors: a step forward in the treatment of depression?].
    Möller HJ; Bauer M; Fritze J; Haen E; Laux G; Müller WE; Rüther E
    MMW Fortschr Med; 2005 Jan; 147(3):43-5. PubMed ID: 15727113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anxiety and depression: which antidepressants treat both at the same time?].
    Laflamme F
    Perspect Infirm; 2010; 7(2):43. PubMed ID: 21744603
    [No Abstract]   [Full Text] [Related]  

  • 5. [The use of antidepressants to treat depression in children and adolescents].
    Desombre H; Paccalin C; Revol O; Fourneret P
    Arch Pediatr; 2006 Jun; 13(6):711-3. PubMed ID: 16697608
    [No Abstract]   [Full Text] [Related]  

  • 6. Selective serotonin reuptake inhibitors in mixed anxiety-depression.
    Berk M
    Int Clin Psychopharmacol; 2000 Aug; 15 Suppl 2():S41-5. PubMed ID: 11110018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression with anxiety and atypical depression.
    Liebowitz MR
    J Clin Psychiatry; 1993 Feb; 54 Suppl():10-4; discussion 15. PubMed ID: 8444829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic action and efficiency of fevarin (fluvoxamine) in patients with non-psychotic anxious and apathic-adynamic depressions].
    Neznamov GG; Siuniakov SA; Teleshova ES; Dorofeeva OA; Chumakov DB; Davydova IA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(8):19-24. PubMed ID: 11552628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxious depression and response to treatment.
    Nelson JC
    Am J Psychiatry; 2008 Mar; 165(3):297-9. PubMed ID: 18316424
    [No Abstract]   [Full Text] [Related]  

  • 10. Understanding the neurobiology of comorbidity in anxiety disorders.
    Nutt DJ; Stein DJ
    CNS Spectr; 2006 Oct; 11(10 Suppl 12):13-20. PubMed ID: 17008826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-daily venlafaxine XR compared with fluoxetine in outpatients with depression and anxiety.
    Judge R; Wagner BE
    J Clin Psychiatry; 1999 Nov; 60(11):795-6. PubMed ID: 10584775
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clomipramine and other serotonin reuptake inhibitors in the treatment of depressed mood, anxiety and impaired impulse control].
    Eriksson E
    Psychiatr Pol; 1994; 28(5):601-12. PubMed ID: 7991713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of patients with depression associated with anxiety symptoms.
    Nutt D
    J Clin Psychiatry; 1997; 58 Suppl 8():11-6. PubMed ID: 9236730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Depression and anxiety in the elderly still underdiagnosed. SSRI preparations in conjunction with psychotherapy provide effective treatment].
    Gottfries CG; Karlsson I
    Lakartidningen; 2001 Feb; 98(8):821-7. PubMed ID: 11265567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SSRIs in anxious-agitated depression: a post-hoc analysis of 279 patients.
    Filteau MJ; Baruch P; Lapierre YD; Bakish D; Blanchard A
    Int Clin Psychopharmacol; 1995 Mar; 10(1):51-4. PubMed ID: 7622805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can recovery from depression be achieved?
    Shelton RC; Tomarken AJ
    Psychiatr Serv; 2001 Nov; 52(11):1469-78. PubMed ID: 11684742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression and anxiety: pharmacological treatment in general practice.
    Ellen S; Selzer R; Norman T; Blashki G
    Aust Fam Physician; 2007 Apr; 36(4):222-8. PubMed ID: 17392933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment response and redefining diagnostic boundaries.
    Hollander E
    CNS Spectr; 2008 Dec; 13(12):1020-1. PubMed ID: 19179937
    [No Abstract]   [Full Text] [Related]  

  • 19. Survivors of torture presenting at an anxiety disorders clinic: symptomatology and pharmacotherapy.
    Bouwer C; Stein DJ
    J Nerv Ment Dis; 1998 May; 186(5):316-8. PubMed ID: 9612450
    [No Abstract]   [Full Text] [Related]  

  • 20. Examination of the decline in symptoms of anxiety and depression in generalized anxiety disorder: impact of anxiety sensitivity on response to pharmacotherapy.
    Olatunji BO; Feldman G; Smits JA; Christian KM; Zalta AK; Pollack MH; Simon NM
    Depress Anxiety; 2008; 25(2):167-71. PubMed ID: 17335002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.